DMPK Services

Our comprehensive DMPK services accelerate drug development by optimizing pharmaceutical compounds through detailed evaluation of key pharmacokinetic parameters, such as oral bioavailability, metabolism, elimination, and therapeutic potential, ensuring informed decision-making and enhanced clinical success.

Within our DMPK department, we house expertly managed in vitro & in vivo metabolite identification, and pre-formulation groups, led by seasoned scientists with a wealth of experience. Our dedicated teams are poised to navigate drug discovery projects by addressing scientific challenges, proposing pivotal modifications to chemical scaffolds, and steering projects towards their intended path.

By mitigating DMPK-related risks at an early stage, we strive to ensure a rapid and cost-effective journey toward successful drug development.

Comprehensive DMPK Services

At Jubilant, our DMPK technical and research services set the industry standard for excellence, tailored to meet the distinctive requirements of our valued clients. Our dedicated team offers unwavering support for integrated pre-clinical discovery programs and fixed-fee-for-services (FFS) projects, consistently delivering results that are both of exceptional quality and reproducibility, all within rapid turnaround times. We prioritize close collaboration with our clients to comprehensively understand their requirements and expectations with regard to time and cost, ensuring a transparent and tailored approach to every project.

Whether you need exploratory ADME screening or detailed pharmacokinetic studies, Jubilant offers a seamless, end-to-end DMPK solution.

Key advantages of our DMPK services include:

  • Full-spectrum in vitro and in vivo ADME studies under one roof
  • GLP-like quality standards ensuring data integrity and compliance
  • Customized study design for small molecules and biologics
  • Proven track record of reproducible, publication-ready results

In vitro DMPK Services

Our dedicated team specializes in delivering comprehensive in vitro ADME (Absorption, Distribution, Metabolism, and Excretion) services, covering essential aspects such as absorption, distribution, metabolism, and excretion. With a wealth of experience, we provide expert guidance throughout the drug discovery journey, spanning from the initial hit identification phase to lead optimization, and ultimately culminating in the identification of clinical candidates.

Our in-depth in vitro ADME services are designed to provide valuable insights and data that help address potential issues and enhance the efficiency of your drug development endeavors.

Drug Metabolism and Pharmacokinetics (DMPK) Services

Key areas of expertise within our In Vitro ADME services include:

Physiochemical Studies:

  • Kinetic solubility assessments.
  • Chemical stability evaluations.
  • Thermodynamic solubility in PBS, SGF, SIF.
  • Early formulation assessments, and more.

In Vitro Metabolism Services:

  • Metabolite stability studies using liver microsomes, hepatocytes, rCYPs, and S-9 fractions.
  • Blood/plasma/brain/tissue/microsomal protein binding studies.
  • CYP phenotyping and CYP induction using PXR cell lines.
  • GSH (Glutathione) adduct evaluations

In Vitro Permeability and Transporter Studies:

  • MDCK/Caco-2 permeability assessments.
  • CYP profiling to understand the involvement of CYP enzymes.
  • TDl (Therapeutic Dose Index), and more.
  • Inhibition and substrate evaluations of P-glycoprotein (P-gp) and BCRP (Breast Cancer Resistance Protein) transporters.
  • CYP (Cytochrome P450) inhibition studies.
  • Stability assessments in plasma, buffer, blood, and blood/plasma ratio.
  • PAMPA (Parallel Artificial Membrane Permeability Assay) studies.

Our in vitro DMPK scientists deliver high-throughput, reproducible data that help streamline candidate prioritization and predict human pharmacokinetics early in the pipeline.


In vivo DMPK and Pharmacokinetic Services 

Our comprehensive in vivo services encompass a wide spectrum of studies to evaluate the pharmacokinetics of compounds. We conduct pharmacokinetic studies using various administration routes, including oral, intraperitoneal, intravenous, subcutaneous, and more, in a range of species, including mice, rats, rabbits, minipigs, and dogs.

Our in vivo services extend to:

  • PK Studies: Investigating pharmacokinetics using various administration routes.
  • Brain Exposure Studies: Evaluating compound penetration and distribution in the brain.
  • Dose Range Finding Studies: Determining the optimal dosing range for compounds.

Additionally, we offer specialized studies, including:

  • Tissue Distribution Studies: Investigating the distribution of compounds in different tissues.
  • Biliary and Urine Excretion Studies: Focusing on biliary and urinary elimination pathways.
  • Excretion Studies: Assessing the elimination of compounds from the body.

Our in vivo pharmacokinetic experts design studies that ensure translational accuracy between preclinical models and human systems, using precise bioanalytical quantification methods to deliver actionable PK insights.